| Entry |
|
|---|
| Name |
Argipressin tannate (USAN);
Pitressin tannate (TN) |
|---|
| Sequence |
Cys Tyr Phe Gln Asn Cys Pro Arg Gly-NH2 (Disulfide bridge: 1-6) |
|---|
| Type |
Peptide |
|---|
| Class |
Cardiovascular agent
DG01952 Vasopressin analog
|
|---|
| Remark |
|
|---|
| Efficacy |
Antidiuretic, Arginine vasopressin receptor agonist |
|---|
| Comment |
Vasopressin derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04270 | Vascular smooth muscle contraction |
| hsa04962 | Vasopressin-regulated water reabsorption |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
H01B POSTERIOR PITUITARY LOBE HORMONES
H01BA Vasopressin and analogues
H01BA01 Vasopressin (Argipressin)
D02983 Argipressin tannate (USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01952 Vasopressin analog
D02983 Argipressin tannate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Vasopressin
AVPR1
D02983 Argipressin tannate (USAN)
AVPR2
D02983 Argipressin tannate (USAN)
|
|---|
| Other DBs |
|
|---|
